SuPine Therapeutics is a research-driven venture company.

Our mission is to develop the first-in-class therapeutics for spinal cord injury to provide patients with better quality of life.

We are developing the therapeutics by establishing innovative two platform technologies (natural polymer-based hydrogel, next-generation stem cell therapy).

Our ultimate goal is to develop innovative treatments for rare diseases with safety (minimal side effects and toxicity) while securing patient's life ethics.